MARSHALL WACE, LLP - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,521,000
-42.5%
472,137
-44.8%
0.01%
-50.0%
Q2 2021$4,383,000
-57.5%
856,053
-44.2%
0.02%
-57.4%
Q1 2021$10,317,000
+6348.1%
1,532,897
+4296.8%
0.05%
+4600.0%
Q4 2020$160,000
-94.6%
34,864
-94.3%
0.00%
-95.0%
Q4 2019$2,940,000
+9700.0%
609,935
+5720.5%
0.02%
Q3 2019$30,000
-99.8%
10,479
-98.9%
0.00%
-100.0%
Q1 2019$13,954,000
+1131.6%
984,550
+1075.7%
0.07%
+450.0%
Q4 2018$1,133,00083,7420.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders